September 7, 2023
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
The purpose of this Notice is to inform potential applicants that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will participate in PAR-23-109, "NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)" effective for the August 8, 2024 due date and subsequent due dates. The following changes and updates have been made to PAR-23-109 (shown in bold italics) to reflect NIAMS' participation in this NOFO.
Part 1. Overview Information
Components of Participating Organizations
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Neurological Disorders and Stroke (NINDS)
National Center for Advancing Translational Sciences (NCATS)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.855, 93.398, 93.867, 93.838, 93.837, 93.839, 93.840, 93.233, 93.172, 93.866, 93.173, 93.279, 93.113, 93.350, 93.121, 93.853, 93.846
Scientific/Research Contact(s)
Marie Mancini, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5032
Email: [email protected]
Financial/Grants Management Contact(s)
Erik Edgerton
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Tel: (301) 594-7760
Email: [email protected]
All other aspects of the NOFO remain the same.
Marie Mancini, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5032
Email: [email protected]